Galectin Therapeutics to Participate in the H.C. Wainwright

NORCROSS, Ga., Oct. 23, 2023 -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, announced today the Company will be participating in the H.C....

Related Keywords

, Jack Callicutt , Polf Boudes , International Study Evaluating The Efficacy , Galectin Therapeutics Inc , Nasdaq , Drug Administration , Globenewswire Inc , Company Contact , Galectin Therapeutic Chief Medical Officer , Seamless Adaptive Phase , Placebo Controlled Multicenter , International Study Evaluating , Esophageal Varices , Company Sponsored Phase , Fatty Liver Disease , Advanced Fibrosis , Fast Track , Chief Financial , Galectin Therapeutic , Markets ,